Darryl S. Baker
2017
In 2017, Darryl S. Baker earned a total compensation of $998.9K as Former Chief Financial Officer at INSYS Therapeutics, a 47% increase compared to previous year.
Compensation breakdown
| Option Awards | $442,983 |
|---|---|
| Salary | $173,250 |
| Stock Awards | $177,100 |
| Other | $205,523 |
| Total | $998,856 |
Baker received $443K in option awards, accounting for 44% of the total pay in 2017.
Baker also received $173.3K in salary, $177.1K in stock awards and $205.5K in other compensation.
Rankings
In 2017, Darryl S. Baker's compensation ranked 8,980th out of 14,666 executives tracked by ExecPay. In other words, Baker earned more than 38.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,980 out of 14,666 | 39th |
Division Manufacturing | 3,438 out of 5,772 | 40th |
Major group Chemicals And Allied Products | 1,174 out of 2,075 | 43rd |
Industry group Drugs | 938 out of 1,731 | 46th |
Industry Pharmaceutical Preparations | 736 out of 1,333 | 45th |
Source: SEC filing on April 16, 2018.
Baker's colleagues
We found five more compensation records of executives who worked with Darryl S. Baker at INSYS Therapeutics in 2017.
2017
Saeed Motahari
INSYS Therapeutics
Chief Executive Officer
2017
Franc Del Fosse
INSYS Therapeutics
General Counsel
2017
Andrew Long
INSYS Therapeutics
Chief Financial Officer
2017
Santosh Vetticaden
INSYS Therapeutics
Chief Executive Officer
2017
John Kapoor
INSYS Therapeutics